Blue Owl Capital Holdings LP
75 holdingsFiling period: 2026-03-31Current AUM: $361.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | AKTS | AKTIS ONCOLOGY INC | 3.16M | $56.6M | $69.8M | 19.28% | -- | 2026-03-31 |
| 2 | LRMR | LARIMAR THERAPEUTICS INC | 7.12M | $32.0M | $27.2M | 7.52% | +296.3K | 2026-03-31 |
| 3 | — | ENGENE HOLDINGS INC | 4.42M | $30.1M | $30.1M | 8.31% | +1.06M | 2026-03-31 |
| 4 | NCDL | NUVEEN CHURCHILL DIRECT LEND | 2.14M | $27.3M | $26.0M | 7.18% | -- | 2026-03-31 |
| 5 | CGEM | CULLINAN THERAPEUTICS INC | 1.91M | $27.1M | $31.5M | 8.71% | -441,208 | 2026-03-31 |
| 6 | OBDC | BLUE OWL CAPITAL CORPORATION | 2.05M | $22.6M | $22.0M | 6.08% | -- | 2026-03-31 |
| 7 | MPLT | MAPLIGHT THERAPEUTICS INC | 1.01M | $20.4M | $13.1M | 3.62% | +678.9K | 2026-03-31 |
| 8 | CMPX | COMPASS THERAPEUTICS INC | 2.94M | $15.6M | $5.6M | 1.55% | -525,000 | 2026-03-31 |
| 9 | CNTX | CONTEXT THERAPEUTICS INC | 5.09M | $13.3M | $3.1M | 0.84% | -2,343,891 | 2026-03-31 |
| 10 | HLLY | HOLLEY INC | 4.24M | $13.0M | $11.3M | 3.13% | +90.3K | 2026-03-31 |
| 11 | EYPT | EYEPOINT INC | 912.6K | $11.8M | $11.2M | 3.09% | +520.0K | 2026-03-31 |
| 12 | CRVS | CORVUS PHARMACEUTICALS INC | 545.0K | $8.0M | $7.2M | 2.00% | -- | 2026-03-31 |
| 13 | CNDT | CONDUENT INC | 5.04M | $6.4M | $7.9M | 2.19% | +214.2K | 2026-03-31 |
| 14 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 302.6K | $6.3M | $7.5M | 2.08% | +90.0K | 2026-03-31 |
| 15 | AQST | AQUESTIVE THERAPEUTICS INC | 1.35M | $5.6M | $5.0M | 1.38% | +822.9K | 2026-03-31 |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | 61.5K | $5.3M | $6.1M | 1.69% | -- | 2026-03-31 |
| 17 | CMPS | COMPASS PATHWAYS PLC | 1.80M | $5.1M | $10.5M | 2.91% | -- | 2026-03-31 |
| 18 | IMMX | IMMIX BIOPHARMA INC | 547.6K | $5.0M | $4.6M | 1.26% | -438,688 | 2026-03-31 |
| 19 | IMA | IMAGENEBIO INC | 959.3K | $4.8M | $5.3M | 1.47% | +135.6K | 2026-03-31 |
| 20 | CVEO | CIVEO CORP CDA | 180.5K | $4.8M | $5.7M | 1.57% | -190,055 | 2026-03-31 |
| 21 | LENZ | LENZ THERAPEUTICS INC | 506.7K | $4.6M | $2.7M | 0.74% | +356.7K | 2026-03-31 |
| 22 | ELDN | ELEDON PHARMACEUTICALS INC | 1.42M | $4.4M | $4.8M | 1.33% | -510,000 | 2026-03-31 |
| 23 | KALV | KALVISTA PHARMACEUTICALS INC | 215.0K | $4.3M | $4.3M | 1.20% | -145,000 | 2026-03-31 |
| 24 | OVID | OVID THERAPEUTICS INC | 1.90M | $4.2M | $4.2M | 1.17% | -- | 2026-03-31 |
| 25 | PVLA | PALVELLA THERAPEUTICS INC NE | 31.3K | $3.9M | $4.3M | 1.20% | -9,000 | 2026-03-31 |
← Scroll →
Page 1 of 3